A new PDUFA target date is April 30, 2025. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for STS101 (dihydroergotamine [DHE] nasal ...

Allergies can trigger both migraine headaches and sinus headaches. These types of headaches can share many symptoms, like a pounding head, intense head pressure, and a stuffy or runny nose.

To alleviate confusion with primary headache disorders like migraine and tension-type headaches, it's now called "headache attributed to disorder of the nose or paranasal sinuses." Catchy ...

Migraine medications fall into two broad categories ... makes it more tolerable for people who are prone to the nausea and vomiting that can sometimes accompany other medications. It is taken as a ...

It helps head off migraines by tightening blood vessels in the brain and preventing the release of substances that cause swelling. It can be injected subcutaneously, usually in the thigh well above ...

Ubrelvy (ubrogepant) is a brand-name oral tablet that’s prescribed to treat migraine episodes with or without an aura in adults. Migraine is a condition that often includes a severe headache and ...

Treatment: A physical therapy program is the first-line treatment over the long haul. But therapies like short-term use of ...

Read on for her answers to frequently asked questions about migraine and menopause. The changes that occur during menopause are called perimenopause. During perimenopause, there are ups and downs ...